DK1994926T3 - Valsartanformuleringer - Google Patents

Valsartanformuleringer

Info

Publication number: DK1994926T3
Authority: DK; Denmark
Prior art keywords: valsartan; formulations; valsartan formulations; active agent; microcrystalline cellulose
Prior art date: 2007-05-24

Application number

DK08104077.6T

Other languages

English (en)

Inventor

Uemit Cifter

Hasan Ali Turp

Ali Tuerkyilmaz

Original Assignee

Sanovel Ilac Sanayi Ve Ticaret

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-24

Filing date

2008-05-23

Publication date

2010-04-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38982518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1994926(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-05-23 Application filed by Sanovel Ilac Sanayi Ve Ticaret filed Critical Sanovel Ilac Sanayi Ve Ticaret

2010-04-26 Application granted granted Critical

2010-04-26 Publication of DK1994926T3 publication Critical patent/DK1994926T3/da

Links

239000004072 C09CA03 - Valsartan Substances 0.000 title abstract 2
SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title abstract 2
229960004699 valsartan Drugs 0.000 title abstract 2
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
229920000881 Modified starch Polymers 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
239000008108 microcrystalline cellulose Substances 0.000 abstract 1
229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK08104077.6T 2007-05-24 2008-05-23 Valsartanformuleringer DK1994926T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
TR2007/03568A TR200703568A1 (tr)	2007-05-24	2007-05-24	Valsartan formülasyonları

Publications (1)

Publication Number	Publication Date
DK1994926T3 true DK1994926T3 (da)	2010-04-26

Family

ID=38982518

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08104077.6T DK1994926T3 (da)	2007-05-24	2008-05-23	Valsartanformuleringer

Country Status (12)

Country	Link
US (1)	US20080293789A1 (da)
EP (1)	EP1994926B9 (da)
AT (1)	ATE451097T1 (da)
CY (1)	CY1109865T1 (da)
DE (1)	DE602008000367D1 (da)
DK (1)	DK1994926T3 (da)
ES (1)	ES2337848T3 (da)
HR (1)	HRP20100120T1 (da)
PL (1)	PL1994926T3 (da)
PT (1)	PT1994926E (da)
SI (1)	SI1994926T1 (da)
TR (1)	TR200703568A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2405899A2 (en) *	2009-03-11	2012-01-18	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
TR201005419A2 (tr) *	2010-07-05	2012-01-23	B�Lg�� Mahmut	Valsartan içeren farmasötik bileşim.
EP2990029A1 (en) *	2014-08-29	2016-03-02	Sandoz Ag	Pharmaceutical compositions comprising Canagliflozin
CN105769788A (zh) *	2016-03-11	2016-07-20	江苏中邦制药有限公司	一种缬沙坦片剂及制备方法
CN105816419A (zh) *	2016-05-26	2016-08-03	陈欣怡	一种包含缬沙坦的药物组合物
CN112826806A (zh) *	2021-01-20	2021-05-25	海南皇隆制药股份有限公司	一种缬沙坦片制备方法和缬沙坦片
CN112807286A (zh) *	2021-01-20	2021-05-18	海南皇隆制药股份有限公司	一种缬沙坦分散片制备方法和缬沙坦分散片
WO2025140517A1 (zh) *	2023-12-28	2025-07-03	和记黄埔医药（上海）有限公司	一种药物组合物及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK117793A3 (en)	1991-04-29	1994-05-11	Merck & Co Inc	Optimized tablet formulation
DE4408497A1 (de)	1994-03-14	1995-09-21	Thomae Gmbh Dr K	Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
HUT76542A (en)	1994-03-17	1997-09-29	Ciba Geigy Ag	Use of valsartan for the preparation of pharmaceutical composition serving for the treatment of diabetic nephropathy
TW442301B (en)	1995-06-07	2001-06-23	Sanofi Synthelabo	Pharmaceutical compositions containing irbesartan
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
ATE524176T1 (de)	1998-12-23	2011-09-15	Novartis Pharma Gmbh	Valsartan tablette
US20020132839A1 (en) *	2000-06-22	2002-09-19	Ganter Sabina Maria	Tablet formulations comprising valsartan
US9173847B2 (en) *	2003-10-10	2015-11-03	Veloxis Pharmaceuticals A/S	Tablet comprising a fibrate
WO2005041941A2 (en)	2003-11-03	2005-05-12	Zentiva, A.S.	Valsartan containing formulation
PT2033629E (pt) *	2004-12-24	2013-01-24	Krka	Composição farmacêutica sólida que compreende valsartan
WO2007026261A2 (en) *	2005-05-18	2007-03-08	Combino Pharm, S.L.	Formulations containing losartan and/or its salts
GT200600371A (es) *	2005-08-17	2007-03-21		Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
AU2006307470A1 (en) *	2005-10-27	2007-05-03	Lupin Limited	Pharmaceutical formulation of losartan
WO2007049291A1 (en) *	2005-10-27	2007-05-03	Lupin Limited	Novel solid dosage forms of valsartan and rochlorothiazide
WO2007052307A2 (en) *	2005-10-31	2007-05-10	Lupin Limited	Stable solid oral dosage forms of valsartan

2007
- 2007-05-24 TR TR2007/03568A patent/TR200703568A1/xx unknown
2008
- 2008-05-23 ES ES08104077T patent/ES2337848T3/es active Active
- 2008-05-23 EP EP08104077A patent/EP1994926B9/en active Active
- 2008-05-23 DE DE602008000367T patent/DE602008000367D1/de active Active
- 2008-05-23 PT PT08104077T patent/PT1994926E/pt unknown
- 2008-05-23 SI SI200830014T patent/SI1994926T1/sl unknown
- 2008-05-23 PL PL08104077T patent/PL1994926T3/pl unknown
- 2008-05-23 US US12/126,353 patent/US20080293789A1/en not_active Abandoned
- 2008-05-23 DK DK08104077.6T patent/DK1994926T3/da active
- 2008-05-23 AT AT08104077T patent/ATE451097T1/de active
2010
- 2010-03-01 CY CY20101100204T patent/CY1109865T1/el unknown
- 2010-03-04 HR HR20100120T patent/HRP20100120T1/hr unknown

Also Published As

Publication number	Publication date
CY1109865T1 (el)	2014-09-10
TR200703568A1 (tr)	2008-07-21
DE602008000367D1 (de)	2010-01-21
HRP20100120T1 (hr)	2010-04-30
SI1994926T1 (sl)	2010-04-30
ATE451097T1 (de)	2009-12-15
PT1994926E (pt)	2010-03-16
EP1994926A1 (en)	2008-11-26
EP1994926B1 (en)	2009-12-09
US20080293789A1 (en)	2008-11-27
ES2337848T3 (es)	2010-04-29
PL1994926T3 (pl)	2010-05-31
EP1994926B9 (en)	2010-05-19

Similar Documents

Publication	Publication Date	Title
CY1109865T1 (el)	2014-09-10	Συνθεσεις βαλσαρτανης
NO20083630L (no)	2008-10-10	Nye pyridinderivater
BRPI0820997A2 (pt)	2014-12-23	Comprimidos de desintegração oral compreendendo difenidramina.
NO20091395L (no)	2009-04-06	Nye tiofenderivater
NO20082793L (no)	2008-06-20	Nye tiofenderivater
MX2010005889A (es)	2010-06-22	Derivados de tiofeno como agonistas de s1p1/edg1.
MY153921A (en)	2015-04-15	Aminopyrazole derivatives
MY154909A (en)	2015-08-28	Novel thiophene derivatives
DK3984528T3 (da)	2023-07-31	Farmaceutiske sammensætninger, som omfatter nilotinib
NO20075298L (no)	2007-12-20	Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20090295L (no)	2009-01-20	Substituerte heteroarylderivater
TNSN08326A1 (en)	2009-12-29	Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX2011012739A (es)	2011-12-16	Derivados fluorados de aminotriazol.
MX350447B (es)	2017-09-07	Composicion farmaceutica de disolucion rapida.
EA201201202A1 (ru)	2013-04-30	Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
UA107671C2 (en)	2015-02-10	N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NI201100227A (es)	2012-03-28	Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
TNSN07337A1 (en)	2008-12-31	Pharmaceutical composition comprising an indolylmaleimide derivative
WO2011037976A3 (en)	2011-08-25	Pramipexole pharmaceutical formulations
MX2009007764A (es)	2009-09-10	Formulacion de nevirapina de liberacion prolongada.
MA32461B1 (fr)	2011-07-03	Dronedarone pour la prevention de cardioversion
ATE533477T1 (de)	2011-12-15	Pharmazeutische zusammensetzungen enthaltend irbesartan
EP2433652A4 (en)	2013-09-25	DRY-COATED MOUTH-CATCHING TABLET
WO2010104485A3 (en)	2010-11-25	Valsartan formulations
EA200801678A1 (ru)	2008-12-30	Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом